Leticia Detrow didn’t have much of a choice. Her sprinting times had plateaued. And, unbeknownst to her, Randy Shank, her track coach at Maryland School for the Deaf, had signed her up for a pair of ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...

DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...

Medical writing assistance was provided by Yolande Chalmers, EMJ, London, UK. The views and opinions expressed in this ...

Burgeoning artificial intelligence technologies are taking some of the complexity out of programming with tools that help ...